ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

June 22, 2001

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013